O'Neill Vincent - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 16, 2024, O'Neill Vincent's relationship to BioXcel Therapeutics, Inc. (BTAI) is Officer (See Remarks), and currently has 3,907 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BTAI insiders.

Data Source: SEC.
O'Neill Vincent - Insider Non-Derivative Transactions of BTAI Common Stock
O'Neill Vincent - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 17, 2024 Sell -- (Common Stock) 138 0.69 3907
Sep 15, 2024 M -- (Common Stock) 521 0 4045
Jun 18, 2024 Sell -- (Common Stock) 155 1.29 3524
Jun 15, 2024 M -- (Common Stock) 521 0 3679
Apr 5, 2024 Sell -- (Common Stock) 165 2.62 5408
Mar 16, 2024 M -- (Common Stock) 2250 0 5573
Mar 15, 2024 M -- (Common Stock) 521 0 3323
Dec 15, 2023 M -- (Common Stock) 521 0 2802
Sep 15, 2023 M -- (Common Stock) 521 0 2281
Jun 15, 2023 M -- (Common Stock) 521 0 1760
Mar 16, 2023 Sell -- (Common Stock) 845 19.7 1239
Mar 15, 2023 M -- (Common Stock) 2084 0 2084
Jan 21, 2023 Sell -- (Common Stock) 29713 30 0
Jan 21, 2023 M -- (Common Stock) 29713 0.41 29713